| 000 | 01644 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514073942.0 | ||
| 264 | 0 | _c20031017 | |
| 008 | 200310s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1093/annonc/mdg316 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoetz, M P | |
| 245 | 0 | 0 |
_aThe Hsp90 chaperone complex as a novel target for cancer therapy. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cAug 2003 |
||
| 300 |
_a1169-76 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aBenzoquinones |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLactams, Macrocyclic |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aQuinones _xpharmacology |
| 650 | 0 | 4 | _aResearch |
| 650 | 0 | 4 |
_aRifabutin _xanalogs & derivatives |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aToft, D O | |
| 700 | 1 | _aAmes, M M | |
| 700 | 1 | _aErlichman, C | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 14 _gno. 8 _gp. 1169-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdg316 _zAvailable from publisher's website |
| 999 |
_c12658456 _d12658456 |
||